Check it out! Was lots of fun. Everyone should have a listen to #theleadcandidate. lnkd.in/eG5gxmya

The most interesting innovations occur at the intersect of disciplines, cultures & ideas (Medici Effect). That is why we're building diversity & multidisciplinarity into Psylo's DNA. Check out this great podcast, starring our superstar Lead Medicinal Chemist, William Jorgensen 🥳

📣 We are thrilled to announce that Psylo has raised a $5M seed round with the support of local & international funds: Main Sequence, Lionheart Ventures, Negev Capital, @EmpathVentures & CaraMed Capital! Congratulations Joshua Ismin e/hed 🥳 👏

What do you think scientists need to be able to achieve great science in academia or in industry? Listen to my chat on #theleadcandidate with William Jorgensen from @Psylo_Bio about science life in both worlds

Excited!

As part of a great team, spanning over a decade of work. My PhD work (along with the projects of many others) made the headlines today: smh.com.au/national/nsw/t…

The reward for me has been working with a stellar team of scientist which started with William Jorgensen 10yrs ago, Dr Katte, Dr Kiyan Afzali, Tristan Reekie, Dr Werry including many others. ‘Think of it like Lego’: The Sydney chemist who found a $273m molecule smh.com.au/national/nsw/t…

I had so much fun last night at our farewell drinks with e/hed 🥳 & the Psylo fam! Thank you to @Psylo_Bio & Joshua Ismin for hosting and to all the wonderful people of Sydney who joined us. I'm so excited for US adventures but it's things like this I'll miss the most 💕

It has been a big month for psychedelic research and the Psylo team. See why in our latest edition of the Psychedelic Science Newsletter, 2023 May 🍄 - mailchi.mp/psylo/psylo-sc…

Psylo's Psychedelic Science Newsletter, 2023 May 🍄 - mailchi.mp/psylo/psylo-sc…

.@Kinoxis_tx is excited to announce US$3.6m grant from NIDAnews to fund the Phase 1 trial for lead drug #KNX100, targeted at addressing opioid withdrawal. Learn more about what this means for Kinoxis, KNX100 and those battling opioids: tinyurl.com/2p99h294 #biotech #science

11000 attendees to Psychedelic Science 2023! Would be cool to chat with some indole chemists out there! Or anyone interested in unique psychedelic scaffolds! psychedelicscience.org

Looking forward to a stellar program at this year's DDI ECR Symposium with talks from Paul Young (Ab Initio), William Jorgensen (Psylo), Jinhan (Angela) Xie (Children’s Cancer Institute) and Ann Na Cho (Macquarie University). Sydney Knowledge Hub @Psylo_Bio Ab Initio Pharma Childrens Cancer Institute

🤝 Teamwork makes the dream work! 🤝 As we reflect on our accomplishments, we're reminded of the commitment our team demonstrates every day. From conquering challenges to embracing new opportunities, we're thankful for the dedication of the outstanding individuals that are Psylo

This was incredible! So excited for SLINGSHOT and Hello Tomorrow global!

🎉 Psylo clinched the win at the Hello Tomorrow APAC Challenge amidst 200+ remarkable contenders. uk.finance.yahoo.com/news/biotechno…

Really humbled by the experience. I presented a small amount of the epic work being done by a world class team spanning every aspect of drug discovery.

A fantastic evening bonding with the @Psylo_Bio crew in stunning Sydney last night! Good vibes, great company and deep nerding out about psychedelic pharmacology and chemistry - what more could you want?

Did you catch my psychedelic science newsletter for Sept? New findings in anxiety, depression & addiction, brain connectivity, predicting efficacy, sex differences, neuroplasticity, new tools, & exploring molecular targets of psychedelics beyond 5-HT2A. psylo.bio/news/psylo-new…

Psylo is joining forces with Tessara Therapeutics & University of Sydney to advance neuroplastogen development for treating addiction! 🚀🧠 We aim to reshape and ‘rewire’ how we tackle substance use disorders. Learn more: prnewswire.com/news-releases/…